Open tender · Germany · Contract notice
Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V über Arzneimittel mit dem Wirkstoff Denosumab Xgeva (ATC-Code nach WHO: M05BX04)
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen
AOK PLUS - Die Gesundheitskasse für Sachsen und Thüringen in Germany is inviting bids for “Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Abs. 8 SGB V über Arzneimittel mit dem Wirkstoff Denosumab Xgeva (ATC-Code nach WHO…”. Bids close on 31 July 2027. To qualify, bidders need at least one similar completed work, ISO 9001 and GST registration.
The work
Conclusion of non-exclusive discount agreements for the medicinal product Denosumab Xgeva (ATC-Code M05BX04) within an Open-House model.
- Participation is open to all interested pharmaceutical companies meeting requirements.
- No individual contract negotiations or exclusivity.
- Absolute silence on the contents of the participation documents is required.
Key facts
- Contract period
- Agreements end no later than May 31, 2027.
- Evaluation
- Not mentioned in the provided text.
- Submission
- Online, on the e-procurement portal
What it takes to qualify
Worth a closer look
- The 'Anschreiben' and 'Erläuterungen der Vertragsbedingungen' in the project room are mentioned as containing the required documents, but their specific contents are not detailed in the excerpt.
Experience
- At least 1 similar work — Not mentioned in the provided text.
- Not mentioned in the provided text.
Certifications and registrations
ISO 9001Not mentioned in the provided text.
GST registrationNot mentioned in the provided text.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- Eigenerklärung zum Nichtvorliegen von AusschlussgründenTo be filled out and submitted with the application.
- Eigenerklärung RusslandsanktionenTo declare no connection to Russia as per EU regulation.